Aims To assess the ability of clinical characteristics, admission ECG and continuous ST segment monitoring in determining long-term prognosis in unstable angina.
Introduction
The varied pathophysiology and outcome of patients admitted with a clinical diagnosis of unstable angina [1] [2] [3] imposes a need for risk stratification of patients to allow targeting of angiography and revascularization. In the early phase following admission, this may best be achieved on the basis of the clinical and non-invasive screening data available to the clinician.
The prognostic importance of refractory angina with significant ECG changes is well recognized [1] ; however, it is less clear whether recurrent chest pain carries the same prognostic importance as the presence of transient ischaemia detected by continuous ST segment monitoring. It is also not known whether the determinants of short-term prognosis in unstable angina extend to prognostic value over the long term.
The purpose of this investigation was to examine the prognostic significance of simple clinical and electrocardiographic variables, including the results of continuous ST segment monitoring, in unselected patients admitted with a clinical diagnosis of unstable angina. We have previously reported [4] the in-hospital outcome of unselected patients with unstable angina according to these variables, and we now extend these observations over long-term (median 2·6 years) follow-up.
Methods
The detailed methods have been described previously [4, 5] . In brief, subjects were recruited from three district general hospitals between 1990-1992 and all results were analysed centrally at the Royal Brompton Hospital. The study received approval from the Ethics committees of all participating centres and all subjects were required to give informed written consent prior to enrolment.
Patients
Subjects aged 30-75 years, presenting within 24 h of an acute episode of anginal pain, requiring emergency admission to the coronary care unit, were recruited. A diagnosis of unstable angina was made on the history and description of chest pain. Patients were included with new onset angina (<1 month); recent deterioration in stable angina with symptoms occurring with minimal effort; rest or nocturnal angina; angina with 1 month of myocardial infarction. Subjects with acute myocardial infarction, (prolonged chest pain of d30 min, and either persisent ST elevation d0·2 mV or clear evidence of evolving Q waves), were excluded. Subjects with electrocardiographic evidence of left ventricular hypertrophy and strain pattern, left bundle branch block morphology, or who were on medications that might have influenced the interpretation of ST segment changes were also excluded.
All patients received oral aspirin 150 mg daily and maximal antianginal therapy consisting of an intravenous infusion of nitrates, an oral beta-blocker; oral diltiazem 60 mg thrice daily, and in accordance with the original study protocol, subjects were randomized to receive either intravenous heparin (titrated to an APTT ratio of 1·5-2·5 of control value), or no heparin. More than 75% of the subjects were able to tolerate oral beta-blockers (158); diltiazem was given to 163 (77%), and virtually all of the patients tolerated intravenous glyceryl triatrate (94%).
Two hundred and eighty five subjects were recruited into the study; however, 73 subjects demonstrated evidence of acute myocardial infarction within the first 24 h, based on serial cardiac enzymes (>2 fold rise above baseline), or development of new Q waves on serial ECGs. These subjects have been excluded from this analysis; the remaining 212 subjects with unstable angina form the basis of this report. Patients were followed-up at 6 weeks, 3 and 6 months after hospital discharge, and final follow-up was performed by telephone contact and by review of case notes.
Chest pain
Detailed chest pain charts were kept by all patients during the period of ST segment monitoring. For each episode of chest pain, the time and duration were recorded as well as the severity, on a scale of 1 (mild) to 10 (severe). Recurrent pain was defined as the development of pain 24 h after optimal medical therapy; severe pain as any pain of greater than 4 on the scale within the 48 h; and prolonged chest pain as a total duration of painful episodes of >6 min over the 48 h period.
Resting ECG
A 12-lead resting ECG was recorded at admission for all patients. Two observers analysed the ECG and were blinded to the clinical outcome and the findings of ST segment monitoring. The presence of ST segment depression of d0·02 mV was noted, as were inverted/ biphasic T waves, and the presence of any conduction abnormalities. Differences between observers were mediated by consensus or by a third observer if consensus could not be reached.
ST segment monitoring
After enrolment and treatment optimization, patients underwent 48 h of continuous ST segment monitoring using frequency modulated Oxford Medilog MR35 dual channel recorders with a frequency response 0·05-40 Hz. Analysis of the tapes was performed at the Royal Brompton Hospital using an Oxford MA20 analyser blinded to clinical outcome. All potential episodes of ST segment depression were identified by visual review at 60-120 times normal speed, which were then printed and measured. The automatic ST trend was also examined for any further possible episodes and these were confirmed by measurement of the printed ECG trace. Significant ST segment depression was defined as d0·1 mV planar or downsloping ST segment depression from baseline at 80 ms after the J point lasting for more than 60 s. ST elevation was defined as the development of d0·2 mV from the J point. Each episode had to be separated by a return of the ST segment to baseline for at least 1 min to be counted as a discrete episode. Changes in the T wave vector in the absence of ST segment changes were not recorded or included in the analysis. The frequency and duration of episodes, and their association with chest pain was also noted. The recruiting centres were not informed of the results of the ST segment monitoring in order to prevent any referral bias.
Outcome
The primary definition of adverse outcome was the occurrence of cardiac death or non-fatal myocardial infarction. Cause of death was determined from the clinical circumstances of the event, the case notes of the hospital where the patient had died, and from postmortem data where available. Myocardial infarction was defined as development of prolonged chest pain with either a greater than two-fold rise in cardiac enzymes above the upper limit of normal, or the development of new Q waves on serial ECGs.
A secondary measure of unfavourable outcome was also defined to include cardiac death, non-fatal myocardial infarction as well as the development of severe angina requiring revascularization, either as an emergency or electively.
Continuous variables are expressed as the mean 1 standard deviation or as median values and range. Two sided P values of significance are quoted throughout with P<0·05 considered to represent significance. Comparisons of categorial variable at baseline was evaluated by chi-square analysis using Yates' correction, and the Fisher's exact test was used where the event rate or characteristic was 5 or less in number. Identification of variables of prognostic importance was performed using univariate Cox regression analysis for the occurrence of death and myocardial infarction, and separately for the composite end-point of unfavourable outcome. Multivariate analysis was performed using a Cox regression model including the variables identified of potential significance from the univariate analysis. A forward stepwise method of entry of variables was used with variables entered if P was <0·2 and removed if P was >0·4. Results are expressed as the Hazard ratio with 95% confidence intervals. Cumulative event free Kaplan-Meier survival curves were constructed for the occurrence of death and non-fatal myocardial infarction, and separately for any adverse event. The log rank test was used to compare survival curves based on presence or absence of admission ECG ST depression and transient ischaemia on continuous ST segment monitoring.
Results
The clinical characteristics of the study population are shown in Table 1 . Almost 80% were males and 29%d65 years. The findings of the admission ECG, the recurrence of chest pain and the findings of ST segment monitoring are shown in Table 2 .
Admission ECG
ECG ST depression was more frequent in older patients. T wave inversion, but not ST depression, was more common in patients with previous stable angina and in those with a previous history of myocardial infarction.
Chest pain
Chest pain recurred after commencement of medical therapy in 134 (63·2%) subjects, in 72 (34·0%) subjects pain having recurred at least 24 h after maximal medical therapy. A total of 421 episodes of pain were recorded, median two per patient, range 1-18 with a median severity of 3 on a scale of 1-10. The median duration of chest pain episodes over the 48 h period was 20 min, ranging from 1-430 min.
ST segment monitoring
Transient ischaemia occurred in 32 (15·1%) patients despite treatment during 8963 h of monitoring (mean 42·3 h per patient). A total of 132 episodes of transient ischaemia were recorded (median 2·5 episodes/48 h), 80% of which were silent (104). The median duration of ischaemia over the 48 h was 55 (2-530) min, with 16 subjects having d30 min of ischaemia/24 h and nine subjects having d60 min of ischaemia per 24 h. Transient ischaemia was more common in patients aged over 65 years and in those with admission ECG ST segment depression (P<0·05). No ischaemia developed in those with a normal ECG. Silent ischaemia as the sole manifestation of recurrent ischaemia occurred in 14 patients during the period of monitoring.
Outcome during follow-up
The prevalence of adverse events is shown in Fig. 1 . Over a median follow-up of 2·6 years, (range 5 days to 4 years; minimum follow-up of event free patients was 2 years), 28 deaths occurred. Cardiac deaths occurred in 21 (9·9%) subjects, due to the fatal myocardial infarctions in eight, sudden death in 11, and two patients dying during emergency CABG. Among the non-cardiac deaths, four were attributable to cancer; one to a stroke; one patient died from alcoholic liver cirrhosis, and there was one death by suicide. Non-fatal myocardial infarction occurred in seven (3·3%) subjects and in total 27 (12·7%) subjects suffered either non-fatal myocardial infarction as the first event or died from cardiac causes. One third (nine) of the serious adverse events, deaths (two), non-fatal myocardial infarctions (seven), had occurred during the in-hospital phase. Four (15%) further events (three deaths, one non-fatal myocardial infarction, occurred within 6 weeks of leaving hospital, and the remsining 14 (51%) events in the subsequent follow-up period of up to 4 years.
Predictors of outcome
Clinical characteristics Table 3 shows that age >65 years, history of hypertension and previous myocardial infarction were the only significant clinical predictors of the occurrence of death or myocardial infarction. Recurrent pain after 24 h was not predictive of death or myocardial infarction, but did predict the likelihood of adverse events when 
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revascularization was included. Severe pain showed a trend towards predicting the likelihood of death of myocardial infarction.
Admission ECG
The predictive value of the admission ECG findings is shown in Table 4 . ST segment depression on the admission ECG was associated with a significantly increased risk of death or myocardial infarction (log rank P=0·0001), and for any adverse event (log rank P=0·002), as shown by Kaplan-Meier survival curves in Fig. 2 . T wave changes were not predictive of outcome. Subjects presenting with a normal ECG had a favourable long-term outcome, with only three (4·9%) of these subjects suffering cardiac death or myocardial infarction, and 17 (28%) undergoing revascularization. Table 4 shows that the presence of transient ischaemia recorded during continuous ST segment monitoring was highly predictive of the risk of subsequent death or myocardial infarction. Patients with a total duration of ischaemia of less than 60 min per 24 h had a 2·7 fold risk (C.I. 0·99-7·24) of death or myocardial infarction, and the risk in those with d60 min of ischaemia per 24 h was over eight-fold (C.I. 3-23). Figure 3 shows survival curves for death or myocardial infarction, and for any adverse event according to the presence or absence of transient ischaemia and in relation to its duration. Ten of the 32 patients (31·3%) with transient ischaemia died or suffered myocardial infarction, compared with 17 out of 180 (9·4%) without (Fig. 4) . Revascaularization rates were, however, similar in patients with and without transient ischaemia. In the 14 patients in whom ST segment monitoring provided the only evidence of recurrent ischaemia, there were five deaths/myocardial infarction (36%), and five subsequently required revascularization (total events 72%) (Fig. 4) .
ST Segment monitoring

Independent predictors of outcome
In the multivariate model shown in Table 5 , a history of hypertension, previous myocardial infarction, and the presence of transient ischaemia retained independent predictive value for risk of subsequent death and myocardial infarction. Age >65 years showed a trend towards independent predictive value. Recurrent chest pain was not independently predictive of death or myocardial infarction, but independently predicted adverse events when revascularization was included.
Discussion
Patients admitted with a clinical diagnosis of unstable angina are a heterogeneous group, with a variety of underlying pathologies and corresponding clinical outcomes. Patients dying from unstable angina have characteristic coronary lesions, demonstrating acute plaque rupture [6] , and patients with angiographic signs of plaque rupture are at increased risk of death and myocardial infarction [7] . In order to treat patients presenting with unstable angina appropriately, it is therefore essential that high risk subgroups, probably with acute rupture of an intracoronary plaque, are identified and revascularized promptly. It is neither currently feasible nor desirable that all patients presenting with chest pain should undergo immediate coronary angiography in order to seek and treat features of plaque rupture, rather, patients should be stratified according to non-invasive, clinical markers, and early intervention targeted at the higher risk groups.
We have shown that such a risk stratification is possible within a group of unselected patients admitted with a clinical diagnosis of unstable angina, based upon clinical characteristics, the findings of the admission electrocardiogram and the results of continuous ST segment monitoring. Increased age, history of hypertension, previous myocardial infarction, ST depression of even a minor degree on the admission ECG, and the presence of transient ischaemia all predict adverse outcome.
Clinical characteristics
This study has shown that clinical factors: increased age, hypertension and previous myocardial infarction are important predictors of long-term prognosis in patients with unstable angina. The association of increased age and multi-vessel coronary disease is well known and probably accounts for most of the increased risk in the older patients. Increased revascularization was, however, not evident among the older subjects in this study, perhaps reflecting referral bias. A history of hypertension was, as expected, associated with a substantial 
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increased risk of death or myocardial infarction, which was independent of other prognostic variables. History of previous myocardial infarction confers increased risk as a consequence of lower myocardial reserve and a greater probability of severe multi-vessel coronary disease. , or more. Transient ischaemia was associated with a poor outcome, which was progressively worse in those with more prolonged ischaemia. (Pooled log rank for death or MI P=0·0001, for any adverse event P=0·002). -=transient ischaemia >60 min; -=transient ischaemia <60 min; -=no transient ischaemia.
Recurrent chest pain was present in over a third of the subjects, 24 h after optimal medical therapy, and hence lacked specificity in predicting death or myocardial infarction. Even when recurrent pain of moderate severity or the total duration of recurrent pain were assessed, the association with increased risk was only modest. Not surprisingly the development of recurrent pain predicted the need for revascularization. Bugiardini et al. [7] , in a recent report of highly selected patients with unstable angina also showed that recurrent angina was a common phenomenon (76%) and predicted the risk of in-hospital adverse outcome only when revascularization was included. Our results seem to be at variance with Gazes' [1] report demonstrating high event rates in those with refractory angina, but the differences are probably accounted for by the high revascularization rate for symptoms in our study, which was not widely available during the era in which Gazes' cohort was collected. Thus recurrence of chest pain is common in patients admitted with unstable angina and while it prompts the physician to revascularize the patient, it does not predict myocardial infarction or death. 
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Admission electrocardiography
We have shown that ST depression is the most malignant baseline ECG variable in unstable angina. ST segment depression, of even a minor degree, was predictive of poor prognosis. The results are consistent with previous studies showing the prognostic importance of segment depression [8] [9] [10] , but our observations extend to the presence of minor degrees of ST segment depression (0·02 mV of ST depression).
Although anterior T wave changes are associated with a high likelihood of a left anterior descending stenosis [11] and others have reported prognostic value for T wave inversion [12] in unselected patients its ECG variable lacks specificity, and may be more likely to reflect past myocardial damage than current myocardial ischaemia (T wave inversion was commoner in patients with previous infarction and angina in our series). In this study, T wave inversion was not associated with an adverse outcome.
The presence of a normal ECG was associated with a low risk of subsequent death and myocardial infarction, but no admission ECG characteristic was independently predictive of adverse outcome.
ST segment monitoring
Several studies have now shown that the detection of transient ischaemia using continuous ST segment monitoring in unstable angina carries important prognostic value [4, 8, [13] [14] [15] [16] . Many of the earlier studies, however, were conducted in pre-selected individuals [8, 14, 15] and without treatment standardization, limiting application of the results. Having previously reported our findings of in-hospital events in unselected patients using ST segment monitoring [4] , we have now extended our observations over the long-term. The presence of transient ischaemia in this study retained independent prognostic value, with an almost three-fold increase in adverse events compared to those without ischaemia. However analysis of the timing of adverse events (Fig. 1) , shows that one-third of such events occur in-hospital, and over 50% of the total adverse events occur within the first 6 weeks. Beyond this stage, there does not appear to be any difference in the survival rates between those with, or without ischaemia. Thus the predictive value of transient ischaemia for the occurrence of myocardial infarction or death in patients with unstable angina who are receiving optimal anti-ischaemic therapy is confined to the short term.
Transient ischaemia, which was mostly silent, appears to have much greater predictive value for adverse outcome than the development of recurrent pain consistent with the findings in one study of highly selected patients [7] . It is at variance with another report [17] , in which recurrent chest pain was considered to be more sensitive than the presence of transient ischaemia for predicting adverse outcome; however, this group included revascularization as an end-point which is likely to have been influenced by the development of recurrent chest pain.
Whilst patients with transient angina had similar rates of revascularization to those without (Fig. 4) , 32 patients (31·3%) with transient ischaemia died or suffered myocardial infarction compared with 9·4% of patients without. Importantly, in 14 patients, the detection of transient ischaemia by ST segment monitoring was the only evidence of recurrent ischaemia, ST segment monitoring therefore identified a group of patients of whom 36% went on to die or suffer myocardial infarction and a further 36% required revascularization (Fig. 4) . Referral for revascularization was not biased by the findings of ST segment monitoring, as the referring hospitals were blinded to these results. Of this group of 14 patients, only four had significant ST depression on the resting electrocardiogram, emphasizing the additional benefit of ST segment monitoring in detecting high risk patients.
Although the study has clearly demonstrated high specificity for adverse outcome in those with transient ischaemia (see Fig. 4) , the sensitivity appears relatively low since 85% of the patients did not develop transient ischaemia, yet 17 (63%) of total non-fatal myocardial infarction's or deaths, and 63 (83%) of all revascularizations had occurred in this group without transient ischaemia. This apparent low sensitivity is based on events occurring over the long-term. Seven out of 13 (54%) early non-fatal myocardial infarction or deaths occurred in patients with transient ischaemia (n=32) and six without ischaemia (n=180), giving a specificity of 87%, a sensitivity of 54% and a negative predictive accuracy of 97%. By contrast, three late (greater than 6 weeks after discharge) non-fatal myocardial infarction or deaths occurred in patients with transient ischaemia (25 event-free at 6 weeks), and 11 in those without any transient ischaemia (174 event-free at 6 weeks). The sensitivity was therefore only 21%, specificity 88% and the negative predictive accuracy 94%. Thus, the presence of transient ischaemia was especially predictive of early events and lack of ischaemia was associated with a favourable early outcome.
Clinical implications
This study shows that unselected patients with unstable angina suffer most adverse events during hospital admission, and in the first few weeks following discharge. Beyond the first few weeks after presentation, however, the long-term outcome of these patients is good. Although many of these patients subsequently undergo revascularization, the low rate of myocardial infarction and death after the early phase is similar to that of patients with stable coronary disease.
Risk stratification should therefore be performed at the earliest opportunity after admission. The resting admission electrocardiogram is useful and demonstrates significant long-term prognostic value. The presence of ST segment depression is associated with a high risk of progression to myocardial infarction, death or development of refractory symptoms, whilst patients with a normal admission ECG are likely to have a favourable outcome.
The demonstration of transient ischaemia on ST segment monitoring, despite medical therapy, is associated with a high risk of progression to myocardial infarction or death. Most of this ischaemic activity is silent and would not otherwise have been detected. Furthermore, recurrent chest pain is common and does not predict adverse outcome. On this basis, serious consideration should be given to the routine use of continuous ST segment monitoring in the assessment of patients presenting with unstable angina. Further evaluation of new antithrombotic and/or, anti-ischaemic treatment regimen need to be considered in those demonstrating transient ischaemia. If transient ischaemia is detected, then early coronary angiography and intervention may improve outcome in these high risk patients.
